About: George Yancopoulos

Facets (new session)
Description
Metadata
Settings
- Rule:
- Inverse Functional Properties:
- "Same As":

About: George Yancopoulos Goto Sponge NotDistinct Permalink

An Entity of Type : yago:Whole100003553, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)
QRcode icon

http://dbpedia.demo.openlinksw.com/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FGeorge_Yancopoulos&invfp=IFP_OFF&sas=SAME_AS_OFF

George D. Yancopoulos (born 1959) is a Greek-American biomedical scientist who is the co-founder, president and chief scientific officer of Regeneron Pharmaceuticals. Yancopoulos is the holder of more than 100 patents. He is a principal inventor and developer of Regeneron's ten FDA-approved or -authorized treatments, as well as of Regeneron's foundational technologies for target and drug development, such as its proprietary TRAP technology, and the VelociGene and VelocImmune antibody technologies.

Attributes	Values
rdf:type	Thing foaf:Person person dul:NaturalPerson Eukaryote Person Human Animal yago:WikicatAmericanBiologists animal eukaryote species yago:WikicatColumbiaUniversityAlumni schema:Person yago:WikicatLivingPeople yago:WikicatPeopleFromQueens,NewYork yago:Alumnus109786338 yago:Biologist109855630 yago:CausalAgent100007347 yago:Intellectual109621545 yago:LivingThing100004258 yago:Object100002684 yago:Organism100004475 yago:Person100007846 yago:PhysicalEntity100001930 yago:YagoLegalActor yago:YagoLegalActorGeo yago:Scholar110557854 yago:Scientist110560637 yago:Whole100003553
rdfs:label	George Yancopoulos (en) Янкопулос, Джордж (ru)
rdfs:comment	George D. Yancopoulos (born 1959) is a Greek-American biomedical scientist who is the co-founder, president and chief scientific officer of Regeneron Pharmaceuticals. Yancopoulos is the holder of more than 100 patents. He is a principal inventor and developer of Regeneron's ten FDA-approved or -authorized treatments, as well as of Regeneron's foundational technologies for target and drug development, such as its proprietary TRAP technology, and the VelociGene and VelocImmune antibody technologies. (en) Джордж (Йо́ргос) Да́мис Янко́пулос (греч. Γιώργος Δάμης Γιανκόπουλος, англ. George Damis Yancopoulos; род. 1959, , Куинс, Нью-Йорк, США) — американский учёный и бизнесмен, один из ведущих в мире . Является , научным директором и президентом биотехнологической компании Regeneron Pharmaceuticals. Миллиардер, один из самых богатых греков США. Согласно Институту научной информации, являлся одиннадцатым в числе самых цитируемых учёных в мире в 1990-х годах, будучи при этом среди них единственным биотехнологом. Первый в мире директор по R&D в фармацевтической отрасли, ставший миллиардером. Член Национальной академии наук США (2004). Адъюнкт-профессор Колумбийского университета. Лауреат (2013), также отмечен NY/NJ CEO Lifetime Achievement Award. (ru)
dcterms:subject	People from Woodside, Queens 1959 births Living people People from Yorktown Heights, New York 21st-century American biologists American people of Greek descent Columbia College (New York) alumni Columbia University Vagelos College of Physicians and Surgeons alumni Fellows of the American Academy of Arts and Sciences Members of the United States National Academy of Sciences The Bronx High School of Science alumni Scientists from New York (state)
Wikipage page ID	5173277 (xsd:integer)
Wikipage revision ID	1118367792 (xsd:integer)
Link from a Wikipage to another Wikipage	People from Woodside, Queens United States 1959 births Living people Columbia University Columbia University Vagelos College of Physicians and Surgeons People from Yorktown Heights, New York Greece Greeks Leonard Schleifer Bachelor of Arts 21st-century American biologists American people of Greek descent Columbia College (New York) alumni Columbia University Vagelos College of Physicians and Surgeons alumni Fellows of the American Academy of Arts and Sciences Members of the United States National Academy of Sciences The Bronx High School of Science The Bronx High School of Science alumni Columbia College of Columbia University American Academy of Arts and Sciences Ernst & Young Entrepreneur of the Year Award FDA Forbes Scientists from New York (state) Regeneron Science Talent Search Frederick Alt PhD Regeneron Pharmaceuticals Regeneron Woodside, New York United States National Academy of Sciences Medical Doctor Yorktown Heights
sameAs	George Yancopoulos George Yancopoulos George Yancopoulos George Yancopoulos George Yancopoulos George Yancopoulos George Yancopoulos
dbp:wikiPageUsesTemplate	dbt:As_of dbt:Authority_control dbt:Cite_journal dbt:Infobox_person dbt:Short_description dbt:Birth_year_and_age
education	Columbia University (en)
occupation	Biomedical scientist (en)
has abstract	George D. Yancopoulos (born 1959) is a Greek-American biomedical scientist who is the co-founder, president and chief scientific officer of Regeneron Pharmaceuticals. Yancopoulos is the holder of more than 100 patents. He is a principal inventor and developer of Regeneron's ten FDA-approved or -authorized treatments, as well as of Regeneron's foundational technologies for target and drug development, such as its proprietary TRAP technology, and the VelociGene and VelocImmune antibody technologies. (en) Джордж (Йо́ргос) Да́мис Янко́пулос (греч. Γιώργος Δάμης Γιανκόπουλος, англ. George Damis Yancopoulos; род. 1959, , Куинс, Нью-Йорк, США) — американский учёный и бизнесмен, один из ведущих в мире . Является , научным директором и президентом биотехнологической компании Regeneron Pharmaceuticals. Миллиардер, один из самых богатых греков США. Согласно Институту научной информации, являлся одиннадцатым в числе самых цитируемых учёных в мире в 1990-х годах, будучи при этом среди них единственным биотехнологом. Первый в мире директор по R&D в фармацевтической отрасли, ставший миллиардером. Член Национальной академии наук США (2004). Адъюнкт-профессор Колумбийского университета. Лауреат (2013), также отмечен NY/NJ CEO Lifetime Achievement Award. (ru)
employer	Regeneron

Faceted Search & Find service v1.17_git139 as of Feb 29 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 58 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software